Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Researchers at Sanofi prepare novel endothelial lipase inhibitors

Jan. 17, 2012

Spherix completes SPX-106 toxicology study for IND submission

Jan. 16, 2012

Pfizer presents new glucokinase activators

Jan. 16, 2012

Chinese company patents novel PPAR agonists

Jan. 16, 2012

Stem Cell Educator therapy evaluated in patients with type 1 diabetes

Jan. 16, 2012

Dosing starts in phase IIa study of Pharmos' levotofisopam

Jan. 13, 2012

New leptin fusion proteins patented by AngioChem

Jan. 13, 2012

Novel chemokine CCR2 receptor antagonists synthesized by Janssen Pharmaceutica

Jan. 13, 2012

Novo Nordisk presents new analogues of fibroblast growth factor 21

Jan. 13, 2012

Phase III data disclosed on Technosphere Insulin versus usual care for diabetes

Jan. 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...